publication date: May. 30, 2014
20140530 - May. 30, 2014
ISSUE 22 – MAY 30, 2014PDF


DePinho Explains Tenure Decision,
Professors Dispute Key Details

Confronted with the prospect of censure by an academic freedom group, Ronald DePinho, president of MD Anderson Cancer Center, is defending his decision to deny tenure renewal to two faculty members.

Responding to an inquiry by the American Association of University Professors, DePinho said that his critics are incorrect in asserting that his administration gave no formal explanation for denying tenure renewal to two faculty members.

photoDePinho’s Letter to the AAUP

Responding to an inquiry by the American Association of University Professors, MD Anderson Cancer Center President Ronald DePinho said his critics are incorrect in asserting that his administration gave no formal explanation for denying tenure renewal to two faculty members.

photoBoyd’s Rebuttal

Douglas Boyd, a professor at MD Anderson, sent his own letter to the American Association of University Professors, responding to DePinho’s version of events.

Boyd is chair of MD Anderson’s Faculty Senate Promotion & Tenure Issues Committee.

photoMoffitt, Ohio State Form Network,
Invite Major Cancer Centers to Join

Moffitt Cancer Center and the Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute earlier this week announced that they are constructing a bioinformatics framework that would enable a multi-center collaboration.

photo
ASCO 2014 Annual Meeting: The Special Awards

 

photoFunding Opportunity
DoD Offering $10.5 Million for Lung Cancer Research

The Department of Defense Lung Cancer Research Program will provide $10.5 million to support innovative, high-impact lung cancer research during fiscal 2014.

photoIn Brief

  • Big Ten Cancer Research Consortium names Susan Goodin exec. officer

  • ASCO launches online resource center for the Affordable Care Act

  • James Graham Brown Cancer Center receives $5.5 million grant

  • MD Anderson signs consulting agreement with Concord Medical Services Holdings for hospital projects in Beijing and Shanghai

  • Mayo Clinic signs agreement with N-of-One for molecular diagnostics

  • CDC is recruiting for director of the Division of Cancer Prevention

photoDrug Approvals

  • FDA approves Vectibix in mCRC with KRAS companion diagnostic

  • European CHMP issues positive opinions for Arzerra in CLL and Halaven in metastatic breast cancer

Copyright (c) 2019 The Cancer Letter Inc.